Lab
New Schryver LLC
New Schryver LLC was paid $3.13M by Medicaid between Jan 2018 and Dec 2024, across 87 billing codes. Its largest line is 80053, Comprehensive metabolic panel — 14% of everything it billed.
33Billing provider infoNEW SCHRYVER LLC
DENVER, CO 80239
DENVER, CO 80239
33aNPI1093756157assigned 06/09/2006
33bProvider typeClinical Medical Laboratory
28Total paid$3.13M
24GClaims695,940
24DCodes billed87
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Colorado
Rank by total paid#12 of 91
Median peer was paid$53K
This provider vs. median59×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official CUOMO, BRIAN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 152,055 | $610K | |
| 2019 | 126,912 | $607K | |
| 2020 | 103,030 | $584K | |
| 2021 | 71,233 | $323K | |
| 2022 | 85,563 | $349K | |
| 2023 | 84,535 | $348K | |
| 2024incomplete | 72,612 | $309K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80053 | Comprehensive metabolic panel | 14% | 57,751 | 43,781 | $445K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 13% | 77,417 | 54,578 | $412K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 7.7% | 11,066 | 9,991 | $241K |
| 84443 | Thyroid stimulating hormone (TSH) | 7.4% | 22,698 | 19,789 | $233K |
| 80048 | Basic metabolic panel (calcium, ionized) | 7.2% | 37,848 | 26,137 | $226K |
| 83036 | Hemoglobin; glycosylated (A1C) | 4.7% | 22,663 | 20,186 | $148K |
| 80061 | Lipid panel | 3.9% | 13,432 | 12,287 | $122K |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | 3.2% | 83,676 | 47,060 | $99K |
| 83880 | 2.5% | 3,462 | 2,826 | $79K | |
| G0471 | Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) | 2.5% | 90,195 | 52,264 | $78K |
| 82607 | 2.1% | 5,827 | 5,237 | $65K | |
| 80164 | 2.0% | 6,230 | 5,226 | $62K |
75 more codes
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.8% | 1,117 | $58K |
| 82140 | 1.8% | 4,817 | $55K | |
| 85610 | 1.6% | 15,946 | $51K | |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | 1.6% | 63,095 | $49K |
| 80202 | 1.5% | 3,751 | $47K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.5% | 1,024 | $47K |
| 36415 | Collection of venous blood by venipuncture | 1.4% | 65,608 | $43K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.4% | 10,194 | $42K |
| 87186 | 1.2% | 6,586 | $37K | |
| 80177 | 1.1% | 3,766 | $35K | |
| 87077 | 1.1% | 6,570 | $35K | |
| 86140 | 1.1% | 8,920 | $34K | |
| 81001 | 1.0% | 14,945 | $32K | |
| 83735 | <1% | 6,621 | $31K | |
| 85027 | <1% | 7,050 | $26K | |
| 83970 | <1% | 849 | $25K | |
| 82746 | <1% | 1,848 | $21K | |
| 84439 | <1% | 3,269 | $21K | |
| 87088 | <1% | 5,179 | $21K | |
| 84134 | <1% | 2,287 | $17K | |
| 87493 | <1% | 866 | $17K | |
| 82728 | <1% | 1,750 | $15K | |
| 85652 | <1% | 7,256 | $14K | |
| 87503 | <1% | 1,014 | $12K | |
| 80076 | <1% | 1,578 | $10K | |
| 83550 | <1% | 1,771 | $10K | |
| 83540 | <1% | 2,192 | $10K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 57 | $9K |
| 87070 | <1% | 1,263 | $9K | |
| 80185 | <1% | 858 | $8K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 340 | $8K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 142 | $8K |
| 80069 | <1% | 1,268 | $8K | |
| 80178 | <1% | 1,213 | $6K | |
| 84153 | <1% | 425 | $6K | |
| 84100 | <1% | 1,747 | $6K | |
| 84436 | <1% | 1,071 | $5K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 235 | $5K |
| 87634 | <1% | 172 | $4K | |
| 86803 | <1% | 364 | $3K | |
| 80050 | General health panel | <1% | 106 | $3K |
| 84550 | <1% | 804 | $3K | |
| 82565 | <1% | 463 | $2K | |
| 87040 | <1% | 324 | $2K | |
| 80175 | <1% | 146 | $1K | |
| 82550 | <1% | 218 | $1K | |
| 80159 | <1% | 72 | $938.26 | |
| 85379 | <1% | 118 | $919.94 | |
| 84480 | <1% | 188 | $755.94 | |
| 82570 | <1% | 353 | $751.54 | |
| 83690 | <1% | 124 | $737.71 | |
| 84479 | <1% | 134 | $710.71 | |
| 86703 | <1% | 115 | $668.14 | |
| 86592 | <1% | 401 | $616.29 | |
| 84481 | <1% | 61 | $547.28 | |
| 82043 | <1% | 212 | $540.18 | |
| 84145 | <1% | 94 | $448.13 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 14 | $299.05 |
| 82248 | <1% | 73 | $258.60 | |
| 84156 | <1% | 108 | $239.84 | |
| 87650 | <1% | 12 | $233.45 | |
| S3600 | Stat laboratory request (situations other than s3601) | <1% | 138 | $231.08 |
| 87045 | <1% | 29 | $176.63 | |
| 80156 | <1% | 27 | $168.18 | |
| 84132 | <1% | 63 | $157.54 | |
| 85018 | <1% | 64 | $113.25 | |
| 85014 | <1% | 46 | $86.80 | |
| 82150 | <1% | 15 | $74.54 | |
| 84520 | <1% | 26 | $69.69 | |
| 83615 | <1% | 13 | $64.03 | |
| 86769 | <1% | 31 | $51.52 | |
| 84460 | <1% | 15 | $51.19 | |
| 82310 | <1% | 12 | $37.81 | |
| 87205 | <1% | 16 | $29.35 | |
| 83605 | <1% | 16 | $1.80 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCUOMO, BRIAN (AUTHORIZED OFFICIAL/CFO)
| Provider | Location | Paid |
|---|---|---|
| Symphony Diagnostic Services No 1 LLC | Sparks, MD | $38.32M |
| Kan-Di-Ki LLC | North Hollywood, CA | $13.48M |
| New Schryver LLC | Denver, CO | $7.16M |
| U S Lab & Radiology LLC | Brockton, MA | $6.73M |
| Kan-Di-Ki LLC | Las Vegas, NV | $3.60M |
| Symphony Diagnostic Services No 1 LLC | Clearwater, FL | $3.22M |
| Community Mobile Diagnostics LLC | San Leandro, CA | $3.15M |
| American Diagnostics Services LLC | Windsor Mill, MD | $3.13M |
| Kan-Di-Ki, LLC | North Hollywood, CA | $784K |
| Kan-Di-Ki LLC | Tukwila, WA | $623K |
| New Schryver LLC | Carrollton, TX | $370K |
| Kan-Di-Ki LLC | Denver, CO | $289K |
| Kan-Di-Ki LLC | North Hollywood, CA | $274K |
| Kan-Di-Ki, LLC | Portland, OR | $268K |
| Kan-Di-Ki, LLC | Las Vegas, NV | $259K |
| Reono Bertagnolli a Medical Group | San Leandro, CA | $216K |
| Kan-Di-Ki, LLC | Phoenix, AZ | $144K |
| Kan Di Ki, LLC | Carrollton, TX | $92K |
| New Schryver LLC | Tukwila, WA | $83K |
| Community Mobile Ultrasound, LLC | Oceanside, CA | $73K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.